Feature

Pandemic effect: All other health care visits can wait


 

A majority of adults are reluctant to visit health care providers unless the visit is related to COVID-19, according to survey conducted at the end of April.

Survey: Most adults would avoid non-COVID-19 treatments

When asked how likely they were to visit a variety of health care settings for treatment not related to the coronavirus, 62% of respondents said it was unlikely that they would go to a hospital, 64% wouldn’t go to a specialist, and 65% would avoid walk-in clinics, digital media company Morning Consult reported May 4.

The only setting with less than a majority on the unlikely-to-visit side was primary physicians, who managed to combine a 39% likely vote with a 13% undecided/no-opinion tally, Morning Consult said after surveying 2,201 adults on April 29-30 (margin of error, ±2 percentage points).

As to when they might feel comfortable making such an in-person visit with their primary physician, 24% of respondents said they would willing to go in the next month, 14% said 2 months, 18% said 3 months, 13% said 6 months, and 10% said more than 6 months, the Morning Consult data show.

“Hospitals, despite being overburdened in recent weeks in coronavirus hot spots such as New York City, have reported dips in revenue as a result of potential patients opting against receiving elective surgeries out of fear of contracting COVID-19,” Morning Consult wrote, and these poll results suggest that “health care companies could continue to feel the pinch as long as the coronavirus lingers.”

Recommended Reading

Reporting for duty at the front lines of COVID-19: From your editor in chief
MDedge Hematology and Oncology
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
MDedge Hematology and Oncology
FDA tightens requirements for COVID-19 antibody tests
MDedge Hematology and Oncology
Cancer screening, monitoring down during pandemic
MDedge Hematology and Oncology
Three months of COVID-19 may mean 80,000 missed cancer diagnoses
MDedge Hematology and Oncology
Case reports illustrate heterogeneity of skin manifestations in COVID patients
MDedge Hematology and Oncology
Doctor with a mask: Enhancing communication and empathy
MDedge Hematology and Oncology
Fountains of Wayne, and a hospitalist’s first day, remembered
MDedge Hematology and Oncology
COVID-19 death rate was twice as high in cancer patients in NYC study
MDedge Hematology and Oncology
FDA grants EUA to muscle stimulator to reduce mechanical ventilator usage
MDedge Hematology and Oncology